MMJ Recs

MAY 29, 2024

This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card. The importance of access to medical marijuana for individuals with qualifying medical conditions cannot be overstated.

Marijuana 52

Marijuana Programs Patients Conditions 52

The Cannigma

JULY 12, 2022

A representative from the Alabama Agriculture Department has stated that licenses for medical marijuana producers won’t be issued before September 2022, and it could take until 2023 to get the program up and running. They cannot access flower or edibles and can only have 70 daily doses at one time with a maximum of 50 mg per dose.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Veriheal

SEPTEMBER 15, 2023

Finally, on April 28, 2023, the first licensed sales commenced with the opening of dispensaries in Marietta and Macon. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.

Programs 62

Programs Legalization Oil Conditions 62

The Cannigma

JULY 5, 2022

Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest. The only way to access the plant and its products is through the legacy market (aka the black market). Possible penalties.

Law 96

Law Decriminalization Programs Patients 96

Veriheal

MARCH 31, 2023

Fast-forward to 2023, and the state has now granted the first of these psilocybin manufacturing licenses to Satori Farms PDX LLC. Unfortunately, the bill specifies that medical cannabis patients will only have access to a limited selection of cannabis products. Let us know in the comments!

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. Starting in 2023, the bill would allow for industrial hemp and medical cannabis production on up to 150 hectares of land.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

PrestoDoctor

FEBRUARY 13, 2023

Louis Skyline – Gateway Arch Getting your Missouri medical marijuanas card in 2023 is still beneficial. Learn about how to become a medical marijuana patient so you can get access to medical cannabis in Missouri. Beginning May 3rd, 2023, dispensaries will be required to scan patient and caregiver cards at the time of purchase.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

Cannabis Law Report

DECEMBER 9, 2019

In fact, the Brightfield Group claims that the CBD market may reach $24 billion by 2023, good news for businesses such as Next Green Wave, Inc. As CBD becomes increasingly prevalent, accessible and mainstream, it is expected that pet-related CBD products will continue to represent a massive opportunity for brands in the market.

Pets 59

Pets CBD Research and Development Epilepsy 59

Veriheal

JUNE 22, 2023

Background of the Case The case involved a 21-year-old defendant facing a DUI charge in early 2023. The legislation permits physicians to recommend cannabis for treating a range of severe medical conditions, such as epilepsy , PTSD , cancer, and glaucoma , to name a few.

Patients 75

Patients Treatment Conditions Cannabis 75

Cannabis Law Report

DECEMBER 30, 2019

Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access. In the existing state-legal regulated marijuana marketplaces, businesses struggle to access basic banking services due to the federal prohibition of marijuana. A Pathway Towards SAFE Banking.

Legislation 59

Legislation Patients Access Banking 59